Literature DB >> 207461

Multi-laboratory comparison of three heparin-Mn2+ precipitation procedures for estimating cholesterol in high-density lipoprotein.

J J Albers, G R Warnick, D Wiebe, P King, P Steiner, L Smith, C Breckenridge, A Chow, K Kuba, S Weidman, H Arnett, P Wood, A Shlagenhaft.   

Abstract

Plasma high-density lipoprotein is commonly estimated by measuring the cholesterol remaining in plasma supernatant solutions after other lipoproteins, which contain apolipoprotein B, are precipitated with heparin and Mn2+. The method (method I) now in use by the Lipid Research Clinics, in which Mn2+ is at 46 mmol/liter final concentration, is reasonably accurate, but precipitation and sedimentation of lipoproteins other than high-density lipoproteins is often incomplete. We evaluated two modifications of method I. In method II, the Mn2+ concentration was doubled; the second modification (method III) included the increased Mn2+ concentration in a combined heparin Mn2+ reagent, decreased sample volume (2 ml), and a shorter incubation time (10 min at room temperature). The percentages of samples with turbid supernates (i.e., incomplete sedimentation) by methods I, II, and III were 9, 3, and 2%, respectively. Among non-turbid supernates, the percentages of samples containing measurable apolipoprotein B (incomplete precipitation) were 79, 19, and 16%, respectively. We conclude that method III is the most convenient and accurate of the three procedures.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 207461

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  43 in total

1.  Quantitation of high density lipoproteins.

Authors:  J J Albers; G R Warnick; M C Chenng
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

2.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

3.  Polymorphisms, de novo lipogenesis, and plasma triglyceride response following fish oil supplementation.

Authors:  Annie Bouchard-Mercier; Iwona Rudkowska; Simone Lemieux; Patrick Couture; Marie-Claude Vohl
Journal:  J Lipid Res       Date:  2013-07-25       Impact factor: 5.922

4.  Association between yogurt consumption, dietary patterns, and cardio-metabolic risk factors.

Authors:  Hubert Cormier; Élisabeth Thifault; Véronique Garneau; Angelo Tremblay; Vicky Drapeau; Louis Pérusse; Marie-Claude Vohl
Journal:  Eur J Nutr       Date:  2015-03-15       Impact factor: 5.614

5.  Exercise in a behavioural weight control programme for obese patients with Type 2 (non-insulin-dependent) diabetes.

Authors:  R R Wing; L H Epstein; M Paternostro-Bayles; A Kriska; M P Nowalk; W Gooding
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

6.  Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation.

Authors:  Iwona Rudkowska; Frédéric Guénard; Pierre Julien; Patrick Couture; Simone Lemieux; Olivier Barbier; Philip C Calder; Anne Marie Minihane; Marie-Claude Vohl
Journal:  J Lipid Res       Date:  2014-05-19       Impact factor: 5.922

7.  The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects.

Authors:  R I Press; J Geller; G W Evans
Journal:  West J Med       Date:  1990-01

8.  Differences in metabolomic and transcriptomic profiles between responders and non-responders to an n-3 polyunsaturated fatty acids (PUFAs) supplementation.

Authors:  Iwona Rudkowska; Ann-Marie Paradis; Elisabeth Thifault; Pierre Julien; Olivier Barbier; Patrick Couture; Simone Lemieux; Marie-Claude Vohl
Journal:  Genes Nutr       Date:  2012-12-19       Impact factor: 5.523

9.  Plasma lipids and insulin in gall stone disease: a case-control study.

Authors:  R K Scragg; G D Calvert; J R Oliver
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-01

10.  Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Joseph Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.